InAADR

Drug Information

Drug Name: Bepotastine (125602-71-3)
PubChem ID: 164522
SMILES: C1CN(CCC1O[C@@H](C2=CC=C(C=C2)Cl)C3=CC=CC=N3)CCCC(=O)O
InchiKey: YWGDOWXRIALTES-NRFANRHFSA-N
Therapeutic Category:

Computed Drug Properties

Molecular Weight (dalton): 388.895
LogP: 4.1702
Ring Count: 2
Hydrogen Bond Acceptor Count: 4
Hydrogen Bond Donor Count: 1
Total Polar Surface Area: 62.66

This panel provides information on interacting drugs and their ADRs along with references

Interacting drug Toxicity Interaction Type Mechanism Reference

This panel provides drug-protein interaction and their ADRs along with references

Toxicity Interacting Protein Mechanism Reference

This panel provides drug-food interactions and their ADRs along with references

Food Toxicity Reference

This panel provides information on metabolites and their ADRs along with references

Metabolite Toxicity Place of Metabolism Mechanism Reference

This panel provides information on drug category

Toxicity Source
Abnormal Behaviour MetaADEDB
Acinetobacter Infection MetaADEDB
Activities Of Daily Living Impaired MetaADEDB
Agranulocytoses MetaADEDB
Allergic Dermatitis MetaADEDB
Alopecia MetaADEDB
Alveolitis MetaADEDB
Amentia MetaADEDB
Anaesthesia MetaADEDB
Anorexia MetaADEDB
Aortic Dissection MetaADEDB
Apathy MetaADEDB
Aptyalism MetaADEDB
Arrhythmia MetaADEDB
Asthma MetaADEDB
Atelectasis MetaADEDB
Band Neutrophil Percentage Increased MetaADEDB
Beta 2 Microglobulin Urine Increased MetaADEDB
Bleb MetaADEDB
Blood Albumin Decreased MetaADEDB
Body Temperature Increased MetaADEDB
Bradycardia MetaADEDB
Cerebrovascular Stenosis MetaADEDB
Chest Pain MetaADEDB
Cholecystitis MetaADEDB
Chronic Myeloid Leukaemia Transformation MetaADEDB
Colitis Ischaemic MetaADEDB
Collagen Disease MetaADEDB
Congenital Eye Disorder MetaADEDB
Crying MetaADEDB
Cryptophthalmos MetaADEDB
Cyanosis MetaADEDB
Death MetaADEDB
Dermatitis Medicamentosa MetaADEDB
Disease Of Liver MetaADEDB
Drug Exposure During Pregnancy MetaADEDB
Dry Skin MetaADEDB
Dysgeusia ADReCS
Eczema MetaADEDB
Edema Extremities MetaADEDB
Electrocardiogram Qt Prolonged MetaADEDB
Epilepsy MetaADEDB
Epistaxis MetaADEDB
Eruption MetaADEDB
Erythema MetaADEDB
Erythema Multiforme MetaADEDB
Excess Potassium MetaADEDB
Eye Irritation ADReCS
Eye Rolling MetaADEDB
Flatulence MetaADEDB
Gallbladder Oedema MetaADEDB
Gastric Polyps MetaADEDB
General Physical Health Deterioration MetaADEDB
Glossitis MetaADEDB
Haemolytic Anaemia MetaADEDB
Headache ADReCS
Hemothorax MetaADEDB
Hepatitis MetaADEDB
High Blood Pressure MetaADEDB
Hodgkin Disease Stage Iii MetaADEDB
Hyperventilation MetaADEDB
Hypoaesthesia MetaADEDB
Hypokalaemia MetaADEDB
Incoherent MetaADEDB
Infusion Related Reaction MetaADEDB
Itch MetaADEDB
Joint Arthroplasty MetaADEDB
Lacrimation Increased MetaADEDB
Leucopenia MetaADEDB
Leukopenia Neonatal MetaADEDB
Lung Neoplasm Malignant MetaADEDB
Malignant Neoplasm Progression MetaADEDB
Malignant Pleural Effusion MetaADEDB
Metastases To Lung MetaADEDB
Multiple Drug Overdose Intentional MetaADEDB
Nail Disorder MetaADEDB
Nasopharyngitis ADReCS
Neutrophil Count Decreased MetaADEDB
Onychoclasis MetaADEDB
Oral Disorder MetaADEDB
Oxygen Saturation Decreased MetaADEDB
Palpitation MetaADEDB
Palsies MetaADEDB
Panic Disorder MetaADEDB
Pharyngeal Inflammation MetaADEDB
Pleurodesis MetaADEDB
Productive Cough MetaADEDB
Protein Total Decreased MetaADEDB
Pruritus Generalised MetaADEDB
Renal Impairment MetaADEDB
Renal Tubular Disorder MetaADEDB
Rhinorrhea MetaADEDB
Skin Necrosis MetaADEDB
Spinal Compression Fracture MetaADEDB
Thoracic Cavity Drainage MetaADEDB
Thyroid Cancer MetaADEDB
Torsade De Pointes MetaADEDB
Upper Respiratory Tract Inflammation MetaADEDB
Varicose Vein MetaADEDB
Ventricular Fibrillation MetaADEDB

InAADR: Drug-Protein-ADRs database